Eyegate Pharmaceuticals
1998
FOUNDED
PUBLIC
STATUS
11-20
EMPLOYEES
EYEG
STOCK SYMBOL
1
INVESTMENTS
$6.85
SHARE PRICE
(As of Friday Closing)
Description
Eyegate Pharmaceuticals Inc is a US-based clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The company's lead product EGP-437 incorporates a reformulated topically active corticosteroid, Dexamethasone Phosphate, that is delivered into the ocular tissues through proprietary drug delivery system, the EyeGate II Delivery System. It mainly develops EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and ciliary body.
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
- 271 Waverley Oaks Road
- Suite 108
- Waltham, MA 02452
- United States
+1 (781) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Eyegate Pharmaceuticals’s full profile, request a free trial.
Eyegate Pharmaceuticals Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.25 - $12.89 | $31.2M | $7.60 | -$2.17 | 363K | 4.55M |
Eyegate Pharmaceuticals Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 5,360 | 10,312 | 9,184 | 9,974 |
| Revenue | 2,686 | 1,653 | 408 | 669 |
| EBITDA | (6,810) | (10,806) | (14,540) | (13,342) |
| Net Income | (6,923) | (10,811) | (13,218) | (13,343) |
| Total Assets | 8,868 | 14,281 | 14,305 | 9,731 |
| Total Debt | 126 | 5 | 16 | 29 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Eyegate Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Eyegate Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookEyegate Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is reserved for PitchBook Platform users. To explore Eyegate Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookEyegate Pharmaceuticals Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DelSiTech | Venture Capital-Backed | Turku, Finland | 0 | 00.000 | 0000000000 | 00.000 |
| 000000 00000000000 | Formerly VC-backed | Bedford, MA | 000 | 00000 | 00000000000 | 00000 |
| 0000 000000000000 | Angel-Backed | Austin, TX | 00.000 | 0000000000 | 00.000 | |
| 0000000 | Formerly VC-backed | Jena, Germany | 00 | 00000 | 000000 - 000 | 00000 |
| 0000 0000000000000 | Formerly VC-backed | Waltham, MA | 000 | 00000 | 000000 - 000 | 00000 |
Eyegate Pharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 000000000000 | 07-Mar-2016 | 000000000000000000 | 00.00 | Pharmaceuticals | 0000000 0000 |
Eyegate Pharmaceuticals Executive Team (7)
2 Former Executives
You’re viewing 5 of 7 executives. Get the full list »Eyegate Pharmaceuticals Board Members (11)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Bernard Malfroy-Camine Ph.D | Self | Board Member | 000 0000 | |
| Morton Goldberg MD | Eyegate Pharmaceuticals | Board Member | 000 0000 | |
| Paul Chaney | Self | Chairman & Board Member | 000 0000 | |
| Praveen Tyle Ph.D | Self | Board Member | 000 0000 | |
| Stephen From | Eyegate Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
5 Former Board Members
You’re viewing 5 of 11 board members. Get the full list »